Erythropoietin enhances hippocampal long-term potentiation and memory

[1]  W. Paulus,et al.  Exploring recombinant human erythropoietin in chronic progressive multiple sclerosis. , 2007, Brain : a journal of neurology.

[2]  C. R. Raymond.  LTP forms 1, 2 and 3: different mechanisms for the ‘long’ in long-term potentiation , 2007, Trends in Neurosciences.

[3]  C. Harmer,et al.  Erythropoietin Enhances Hippocampal Response during Memory Retrieval in Humans , 2007, The Journal of Neuroscience.

[4]  Justin Toupin,et al.  Electrical stimulation protocols for hippocampal synaptic plasticity and neuronal hyper-excitability: Are they effective or relevant? , 2007, Experimental Neurology.

[5]  J. Aldenhoff,et al.  Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin , 2007, Molecular Psychiatry.

[6]  Joseph E. LeDoux,et al.  Long-term potentiation in the amygdala: A cellular mechanism of fear learning and memory , 2007, Neuropharmacology.

[7]  T. Bliss,et al.  Plasticity in the human central nervous system. , 2006, Brain : a journal of neurology.

[8]  T. Knöpfel,et al.  Involvement of Protein Synthesis and Degradation in Long-Term Potentiation of Schaffer Collateral CA1 Synapses , 2006, The Journal of Neuroscience.

[9]  J. Kramer,et al.  Fresh Blood and Aged Stored Blood Are Equally Efficacious in Immediately Reversing Anemia-induced Brain Oxygenation Deficits in Humans , 2006, Anesthesiology.

[10]  H. Ehrenreich,et al.  The Brain Erythropoietin System and its Potential for Therapeutic Exploitation in Brain Disease , 2006, Journal of neurosurgical anesthesiology.

[11]  J. Frahm,et al.  Global brain atrophy after unilateral parietal lesion and its prevention by erythropoietin. , 2006, Brain : a journal of neurology.

[12]  Robert E Kass,et al.  Statistical issues in the analysis of neuronal data. , 2005, Journal of neurophysiology.

[13]  A. Cerami,et al.  Emerging biological roles for erythropoietin in the nervous system , 2005, Nature Reviews Neuroscience.

[14]  W. Jelkmann,et al.  Effects of erythropoietin on brain function. , 2005, Current pharmaceutical biotechnology.

[15]  P. Gruss,et al.  Genetic ablation of the mammillary bodies in the Foxb1 mutant mouse leads to selective deficit of spatial working memory , 2005, The European journal of neuroscience.

[16]  H. Ozkan,et al.  Erythropoietin improves long-term spatial memory deficits and brain injury following neonatal hypoxia–ischemia in rats , 2004, Behavioural Brain Research.

[17]  Z. Erbayraktar,et al.  Derivatives of Erythropoietin That Are Tissue Protective But Not Erythropoietic , 2004, Science.

[18]  R. Kass,et al.  Multiple neural spike train data analysis: state-of-the-art and future challenges , 2004, Nature Neuroscience.

[19]  S. Juul.  Recombinant erythropoietin as a neuroprotective treatment: in vitro and in vivo models. , 2004, Clinics in perinatology.

[20]  R. Huganir,et al.  MAPK cascade signalling and synaptic plasticity , 2004, Nature Reviews Neuroscience.

[21]  K. Miskowiak,et al.  Erythropoietin improves place learning in fimbria–fornix-transected rats and modifies the search pattern of normal rats , 2004, Pharmacology Biochemistry and Behavior.

[22]  S. Cohen-Cory.  The Developing Synapse: Construction and Modulation of Synaptic Structures and Circuits , 2002, Science.

[23]  T. Bliss,et al.  The Role of Extracellular Regulated Kinases I/II in Late-Phase Long-Term Potentiation , 2002, The Journal of Neuroscience.

[24]  M. Timme,et al.  Prevalence of unstable attractors in networks of pulse-coupled oscillators. , 2002, Physical review letters.

[25]  F. Squadrito,et al.  Erythropoietin prevents cognition impairment induced by transient brain ischemia in gerbils. , 2002, European journal of pharmacology.

[26]  Kazuki Sato,et al.  Erythropoietin Receptor-mediated Inhibition of Exocytotic Glutamate Release Confers Neuroprotection during Chemical Ischemia* , 2001, The Journal of Biological Chemistry.

[27]  Stuart A. Lipton,et al.  Erythropoietin-mediated neuroprotection involves cross-talk between Jak2 and NF-κB signalling cascades , 2001, Nature.

[28]  P. Lewczuk,et al.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Eric R Kandel,et al.  ERK Plays a Regulatory Role in Induction of LTP by Theta Frequency Stimulation and Its Modulation by β-Adrenergic Receptors , 1999, Neuron.

[30]  P. Patterson,et al.  Cytokine and Growth Factor Involvement in Long-Term Potentiation , 1999, Molecular and Cellular Neuroscience.

[31]  W. Brown,et al.  Normalizing hematocrit in dialysis patients improves brain function. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  S. Masuda,et al.  Erythropoietin prevents place navigation disability and cortical infarction in rats with permanent occlusion of the middle cerebral artery. , 1998, Biochemical and biophysical research communications.

[33]  Christian Rosenmund,et al.  Definition of the Readily Releasable Pool of Vesicles at Hippocampal Synapses , 1996, Neuron.

[34]  D. Ingram,et al.  Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice , 1996, Physiology & Behavior.

[35]  K. Yamagishi,et al.  A novel site of erythropoietin production. Oxygen-dependent production in cultured rat astrocytes. , 1994, The Journal of biological chemistry.

[36]  Hansel,et al.  Clustering and slow switching in globally coupled phase oscillators. , 1993, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[37]  S. Masuda,et al.  Functional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cells. , 1993, The Journal of biological chemistry.

[38]  A. Nissenson,et al.  Epoetin and cognitive function. , 1992, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  M. Fanselow,et al.  Modality-specific retrograde amnesia of fear. , 1992, Science.

[40]  W. Jelkmann.  Erythropoietin: structure, control of production, and function. , 1992, Physiological reviews.

[41]  Joseph E LeDoux,et al.  Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning. , 1992, Behavioral neuroscience.

[42]  C. Stevens,et al.  Excitatory and inhibitory autaptic currents in isolated hippocampal neurons maintained in cell culture. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Banker,et al.  Experimental observations on the development of polarity by hippocampal neurons in culture , 1989, The Journal of cell biology.

[44]  G. Banker,et al.  The establishment of polarity by hippocampal neurons in culture , 1988, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  H. Ehrenreich,et al.  Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition. , 2008, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[46]  P. Falkai,et al.  Erythropoietin: a candidate compound for neuroprotection in schizophrenia , 2004, Molecular Psychiatry.

[47]  M. Gassmann,et al.  Non-erythroid functions of erythropoietin. , 2003, Advances in experimental medicine and biology.

[48]  W. Regehr,et al.  Short-term synaptic plasticity. , 2002, Annual review of physiology.

[49]  J. Spivak.  Erythropoietin use and abuse: When physiology and pharmacology collide. , 2001, Advances in experimental medicine and biology.

[50]  J. Spivak.  Erythropoietin use and abuse , 2001 .